Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Foghorn Therapeutics Inc?

Accepted Answer

Según el último estado financiero (Form-10K), Foghorn Therapeutics Inc tiene un total de activos de $283, una ganancia neta loss de $-86

Question 2

¿Cuáles son los ratios financieros clave para FHTX?

Accepted Answer

El ratio corriente de Foghorn Therapeutics Inc es 0.86, el margen neto es -390.9, las ventas por acción son $0.4.

Question 3

¿Cómo se desglosan los ingresos de Foghorn Therapeutics Inc por segmento o geografía?

Accepted Answer

Foghorn Therapeutics Inc largest revenue segment is Medicines, at a revenue of 22,602,000 in the most earnings release.For geography, United States is the primary market for Foghorn Therapeutics Inc, at a revenue of 22,602,000.

Question 4

¿Es rentable Foghorn Therapeutics Inc?

Accepted Answer

no, según los últimos estados financieros, Foghorn Therapeutics Inc tiene una ganancia neta loss de $-86

Question 5

¿Tiene Foghorn Therapeutics Inc alguna deuda?

Accepted Answer

yes, Foghorn Therapeutics Inc tiene una deuda de 329

Question 6

¿Cuántas acciones en circulación tiene Foghorn Therapeutics Inc?

Accepted Answer

Foghorn Therapeutics Inc tiene un total de acciones en circulación de 55.59

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	24	22	34	19	1	0
Revenue Growth (YoY)	-31%	-35%	79%	1,800%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	27	28	32	30	21	11
Research & Development	88	94	109	105	80	57
Operating Expenses	116	122	142	136	102	68
Other Non Operating Income (Expenses)	4	4	2	2	2	0
Pretax Income	-75	-86	-94	-108	-101	-68
Income Tax Expense	--	0	4	--	--	--
Net Income	-75	-86	-98	-108	-101	-68
Net Income Growth	-13%	-12%	-9%	7%	49%	33%
Shares Outstanding (Diluted)	62.97	54.89	41.97	41.59	37.17	36.79
Shares Change (YoY)	22%	31%	1%	12%	1%	238%
EPS (Diluted)	-1.2	-1.57	-2.34	-2.62	-2.73	-1.87
EPS Growth	-28%	-33%	-11%	-4%	46%	-60%
Free Cash Flow	-91	-101	-119	192	-53	-47
Free Cash Flow Per Share	-1.44	-1.83	-2.83	4.61	-1.42	-1.27
Gross Margin	--	--	--	--	--	--
Operating Margin	-379.16%	-454.54%	-314.7%	-615.78%	-10,000%	0%
Profit Margin	-312.5%	-390.9%	-288.23%	-568.42%	-10,100%	0%
Free Cash Flow Margin	-379.16%	-459.09%	-350%	1,010.52%	-5,300%	0%
EBITDA	-88	-97	-104	-114	-97	-67
EBITDA Margin	-366.66%	-440.9%	-305.88%	-600%	-9,700%	0%
D&A For EBITDA	3	3	3	3	3	1
EBIT	-91	-100	-107	-117	-100	-68
EBIT Margin	-379.16%	-454.54%	-314.7%	-615.78%	-10,000%	0%
Effective Tax Rate	--	0%	-4.25%	--	--	--

Foghorn Therapeutics Inc (FHTX) Price

FHTX Stock Price Chart

FHTX Income

Follow-Up Questions